Corneal reepithelialization and anti-inflammatory agents.

Area of Science:

• Ophthalmology
• Wound Healing
• Pharmacology

Background:

• Corneal injury triggers inflammatory cell infiltration (PMN).
• Ocular inflammation requires safe and effective therapeutic interventions.
• Understanding drug effects on corneal and conjunctival epithelial cell reepithelialization is crucial.

Purpose of the Study:

• To evaluate the impact of nonsteroidal anti-inflammatory agents and corticosteroids on corneal wound healing.
• To determine the safety of these agents in the presence of corneal epithelial defects.
• To elucidate the mechanism of corticosteroid-induced inhibition of reepithelialization.

Main Methods:

• Inhibition of polymorphonuclear leukocyte (PMN) arrival was assessed following corneal injury.
• Reepithelialization rates of corneal and conjunctival epithelial cells were measured.
• The effect of pre-treatment versus post-treatment with corticosteroids was investigated.
• Steroid antagonism and potential inhibitory protein formation were explored.

Main Results:

• Nonsteroidal anti-inflammatory agents inhibited PMN arrival but not reepithelialization.
• Corticosteroids inhibited conjunctival epithelial cell reepithelialization but not corneal epithelial cell reepithelialization.
• Steroid inhibition was dose-dependent, temporary, and reversible with antagonists.
• Steroid effects were not observed with pre-treatment, suggesting a post-injury mechanism.

Conclusions:

• Nonsteroidal anti-inflammatory agents are safe for ocular inflammation with epithelial defects.
• Corticosteroids can be used cautiously in intact corneas, with awareness of potential temporary healing delays.
• Steroid-induced inhibition of reepithelialization involves specific receptors and potentially an inhibitory protein.
• Further research into this inhibitory protein could lead to novel anti-inflammatory therapies without steroid side effects.